What does LiquidCMO Do?

 

Theories for cetyl-myristoleate mechanism(s) of action

In medical terms, LiquidCMO is an adaptagenic immunomodulator that is thought to work with the human body’s immune system to regulate and correct autoimmune programs within the body’s memory T-cells.

While there is much anecdotal information on the treatment of a wide variety of inflammatory diseases using cetyl-myristoleate, little has been noted in the literature for the treatment of Fibromyalgia with any form of CMO. Since limited research has been conducted on the effectiveness of CMO for the treatment of FM, and with apparent success for the treatment of other inflammatory diseases, a clinical study was initiated to document the effectiveness of LiquidCMO on FM. The purpose of this clinical study was to evaluate the benefit of a novel liquid form of CMO (LiquidCMO) for FM. Based on previous studies involving pain syndromes; LiquidCMO was hypothesized to provide symptomatic relief for FM symptoms, without unwanted or harmful side effects. The goal of the study was to use statistical analysis to quantify subjective findings using the SF- 36® Health Survey, showing improvement in physical, mental and emotional well being in subjects with clinically diagnosed FM.

It is only now, after seven years of additional research, and four more years of human trials, that we have finally perfected this exclusive liquid emulsion formula. LiquidCMO is 10 times more powerful than anything other CMO product on the market today!
In laymen’s terms, LiquidCMO has been found through clinical studies and client testimonies to benefit many ailments with autoimmune components such as and including: Fibromyalgia, Osteoarthritis, and Rheumatoid Arthritis. People who suffer with these autoimmune diseases have experienced restorative health benefits after starting a LiquidCMO program. Stiffness, pain and swollen joints have decreased or vanished. They have returned to health!

The exact mechanisms of actions of cetyl-myristoleate are not known at this time. It has been postulated that CMO (a fatty acid ester) may play a role similar to other fatty acids such as those found in fish oils. Fatty acids of this class are known to block the production of pro-inflammatory cytokines (Prostaglandin series II, Leukotriene series IV) and encourage production of anti-inflammatory cytokines (Prostaglandin series III, Leukotriene series V). Prostaglandins and Leukotrienes are unsaturated fatty acids, which regulate local metabolic processes including inflammation, platelet aggregation, pain, fluid balance, and nerve transmission. It has been reported that myristoleic acid inhibits 5-Lipoxygenase in tissue, which understandably would lead to reduction of both inflammation and pain. It has also been noted that cetyl-myristoleate acts as a surfactant, which lubricates joints, but this is highly speculative and unproven at this time. Other suggested roles include incorporation of these fatty acid esters into phospholipid cell membranes and increasing cell membrane fluidity (a well known function of fish oil fatty acids), thus altering phospholipid membrane permeability.